Email not displaying properly? View email in your browser
Advertise | Archives
Teva Pharma to invest $200mn on Labrys Biologics

ABQ’s OsoBio to be sold for $110mn

GlaxoSmithKline in $350mn Oncology medicine Venture

Press Releases
Kite Pharma Files Registration Statement for Proposed Initial...

Ohr Pharmaceutical Announces Closing of SKS Ocular takeover

Ventrus Biosciences to Merge With Assembly Pharmaceuticals

Jun 9th - Jun 12th
World Vaccine Congress Asia

Jun 11th - Jun 12th
Pharma Outsourcing and Procurement Summit 2014

Jun 23rd - Jun 24th
Global Pharma Manufacturing Summit 2014

What can recent mergers mean for the future of pharmaceutical industry?
Valeant Pharmaceutical’s latest bid to acquire Botox maker Allergan for $50bn, a jump from the earlier quoted $47bn, is yet another good example of that model, as was Actavis’ $25bn bid earlier this year for Forest Labs, and is still awaiting court settlement.
Read More»»
patents on new medicines
Merck to Invest € 50mn in Italian Production Site in Bari
Merck today announced plans to invest € 50mn in its Italian production site in Bari in order to respond to the rising demand for biopharmaceuticals. The announcement was made by Karl-Ludwig Kley, Chairman of the Executive Board of Merck, during a press conference held today at the Bari plant,...
Featured Products    
Plasma Technology
Clinalfa® is Bachem`s brand for the production and release of sterile products...
CO2 sensor for bioprocesses
Bench Top
All models in the compact bench top range offer forced air cooling and media warming...
Hapa 800 WebJet
Twin scrw Granulator
New technology for continuous production of water soluble granules containing...
Advertise With Us | Buyer Registration | Subscribe | Unsubscribe